Views & Analysis | Perspectives on pharma industry issues

R&D

A certificate of analysis should be evidence, not a sales do...

Regulators weighing peptide bulk substances can ask whether today's documentation rules fit the risks of this supply chain.

R&D

From phase 1 to phase 3: Scaling radiopharmaceutical trials

Success in radiopharmaceutical development depends on creating and maintaining an integrated, scalable system.

Patients

pharmaphorum podcast Episode 285, Donna Cryer, CryerHealth, LLC

Patients not just at the table, but creating their own: In c...

Donna Cryer, founding partner and Chief Patient Officer of CryerHealth, LLC discusses why is patient inclusion is not the same as patient leadership.

R&D

Gravity is an experimental variable pharma has rarely been a...

Microgravity should not be a destination for pharmaceutical R&D, but another experimental environment.

Digital

Sponsored

Antiviral development in the age of AI: From pre-IND to earl...

hVIVO experts discuss how advancements in AI and machine learning are pushing industry beyond the bounds of a traditional "one virus, one drug" model.

Articles

Immigration: filling the skills gap in the pharmaceutical in...

Jayne Sinclair walks us through the UK laws of immigration that are applicable to the pharmaceutical industry. Graduates in science, technology, engineering and maths are vital for the UK’s future prosperity but are in short supply because...

Articles

Should patients accept not getting their medicine as a price...

Paul Gershlick addresses the problem of exploring drug shortages in the UK and asks how this can be resolved. Two years ago, Alan’s world was turned upside down. Like 40,000 other people a year diagnosed in the UK, he was told he...

Articles

CME: the first step is understanding how we learn

We interview Dr Jonas Nordquist on how we can improve CME-CPD events using the latest research into understanding how we learn. Plenary sessions, breakout groups and patient role play – sound familiar? CME-CPD events don’t necessarily need to follow the default model...

Sales & Marketing

Sponsored

Solution Spotlight: BrandPRO Biopharma

Strong strategy on paper can unravel when priorities collide. BrandPRO Biopharma gives pharmaceutical teams a place to put their decisions to the test

Sales & Marketing

Benefits of marketing with AI tools, upward trajectory graph

Ending rational disengagement: Bridging the strategy-reality...

Organisations must secure strategic buy-in, embed platforms in existing workflows, and provide reps with actionable physician-ready hypotheses.

Digital

Sponsored

Antiviral development in the age of AI: From pre-IND to earl...

hVIVO experts discuss how advancements in AI and machine learning are pushing industry beyond the bounds of a traditional "one virus, one drug" model.

Digital